MYX vs PAR

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

MYX

M PHARMA FPO [MYX]

51MEDIUM

PAR

PARA BIO FPO [PAR]

48LOW

Score Breakdown

MYX PAR
Technical
51
53
Catalyst
53
51
Sentiment
50
50
Fundamental
85
60
Momentum
38
42
Risk Gate
42
50

Key Metrics

MYX Metric PAR
$233.2MMarket Cap$99.4M
291KAvg Volume (20d)2.2M
+2.5%Short InterestN/A
$6.50052-Week High$0.470
$2.04052-Week Low$0.135
-0.7%Daily Change-7.4%
$2.810Reference Price$0.162
-20.6%ROE-180.2%
-20.4%Profit MarginN/A

Active Signals

MYX Signals

Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.6x)
EPS estimates revised upward (+10pts)
Near 52-week low (19% of range)
CANSLIM I: Institutional ownership (36%)
Deeply negative margins (-20%)

PAR Signals

RSI drifting toward oversold territory — worth watching
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Drifting lower — down 4.7% over the last 5 days
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Low cash runway (2 quarters) - dilution risk
Very high P/S ratio (11766.1x)
Strong revenue growth (+51%)

Ask Scout AI to compare MYX and PAR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

MYX vs RCE →MYX vs VIT →NAN vs NUZ →NAN vs PCK →NAN vs PEB →
MYX Full Analysis → PAR Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).